Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

Detalles Bibliográficos
Autores principales: Phillips, KA, Milne, RL, Rookus, MA, Goldgar, D, Friedlander, M, McLachlan, SA, Buys, S, Antoniou, AC, Birch, K, Terry, MB, Easton, DF, Weideman, P, Daly, M, Andrieu, N, John, EM, Hooning, MJ, Andrulis, IL, Caldes, T, Olsson, H, Hopper, JL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395384/
http://dx.doi.org/10.1186/1897-4287-10-S2-A11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395384/
http://dx.doi.org/10.1186/1897-4287-10-S2-A11

Ejemplares similares